India — Fishery/Seafood Products — Fish-Other

← back to leaderboard

India received 15 FDA import refusals in Fish-Other, part of Fishery/Seafood Products between 2023-Q3 and 2026-Q2. Volume peaked at 4 in 2025-Q3, with the trend rising sharply year-on-year. The most-cited issues are filthy, salmonella, and pois chlor. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 12 were hazard refusals and 3 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

3 2023-Q3 2023-Q3: 3 2 2023-Q4 2023-Q4: 2 0 2024-Q1 2024-Q1: 0 0 2024-Q2 2024-Q2: 0 0 2024-Q3 2024-Q3: 0 0 2024-Q4 2024-Q4: 0 0 2025-Q1 2025-Q1: 0 2 2025-Q2 2025-Q2: 2 4 2025-Q3 2025-Q3: 4 1 2025-Q4 2025-Q4: 1 1 2026-Q1 2026-Q1: 1 2 2026-Q2 2026-Q2: 2

Recent rejections